NCT02185989

Brief Summary

Early mobilization (from the first day if possible), first passive and then passive and active, is recommended for critically ill patients in whom it reduces the duration of mechanical ventilation, the length of hospital stay, improves functional status, muscle strength and quality of life after hospital discharge. The early addition of leg bicycling on a cyclo-ergometer is now part of common practice in the ICU. It can preserve or improve muscle strength and further increase the beneficial effects of early mobilization. Electrical muscle stimulation of the quadriceps, is practiced in some intensive care units, and it should, in theory, also through an improvement of muscle strength, increase the beneficial effects of early mobilization. We hypothesized that early quadriceps electrical stimulation and early work on a cyclo-ergometer associated with a standard protocol of early passive/active mobilization in the ICU may improve muscle function and reduce the duration of mechanical ventilation, length of stay, the number of readmissions and improve the quality of life in the mid term in critically ill patients, as compared to a conventional protocol of early passive/active mobilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
314

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 10, 2014

Completed
5 days until next milestone

Study Start

First participant enrolled

July 15, 2014

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2016

Completed
Last Updated

April 13, 2017

Status Verified

April 1, 2017

Enrollment Period

2.4 years

First QC Date

July 4, 2014

Last Update Submit

April 12, 2017

Conditions

Keywords

Critical Illness/*rehabilitationHumans*Intensive Care UnitsMuscle Weakness/diagnosis/*etiology/physiopathology/prevention & controlPolyneuropathies/diagnosis/*etiology/physiopathology

Outcome Measures

Primary Outcomes (1)

  • Global muscle strength assessed by the MRC (Medical research Council, 1978) score

    Global muscle strength assessed by the MRC (Medical research Council, 1978) score on the day of ICU discharge (+/- 1 day) in all enrolled patients discharged alive from the ICU. This evaluation will be conducted by a physiotherapist blinded to the randomization group

    on the day of ICU discharge (+/- 1 day)

Secondary Outcomes (3)

  • Changes in thickness of the rectus femoris muscle of each thigh

    from inclusion to ICU discharge (+ / - 1 day)

  • Frequency of delirium in the ICU.

    During ICU stay

  • Quality of life

    6 months after ICU discharge

Study Arms (2)

Electrical muscle stimulation and bicycling

ACTIVE COMPARATOR

Patients will undergo early electrical stimulation of the quadriceps and early leg bicycling in addition to routine care (which comprises early standard mobilization)

Other: Early electrical stimulation and early leg bicycling added to early standard rehabilitation

Standard early passive/active rehabilitation

NO INTERVENTION

In this control group, patients will undergo routine care that comprises standard early passive/active rehabilitation delivered by physiotherapist with the assistance of ICU nurses

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18 yrs
  • expected length of stay in the ICU higher than 72 hours
  • motor autonomy sufficient for independent ambulation (ass assessed by patient/family/familial practitioner interview

You may not qualify if:

  • Opposition expressed by the patient, his/her legal representative or a member of his/her family
  • Pregnant woman
  • Patient carrying a pacemaker or an implantable defibrillator
  • Patient under extracorporeal membrane oxygenation
  • Severe acute cerebral disease requiring deep sedation
  • Brain death
  • Guillain-Barré syndrome
  • Myasthenia gravis
  • Known Dementia than can affect the main endpoint assessment
  • Deep venous thrombosis or pulmonary embolism treated for less than 48 hours, or floating clot in femoral, iliac of inferior vena cava veins
  • Unstable traumatic injuries of the spine
  • Severe skin disease or surgical reasons that either prevent performing electrostimulation or bicycling in the next 2 days, or prevent patient's verticalization or transfer to chair in the next 5 days
  • Amputation of a lower limb at the trans-metatarsal level or higher
  • Moribund patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Régional d'Orléans

Orléans, 45000, France

Location

Related Publications (1)

  • Fossat G, Baudin F, Courtes L, Bobet S, Dupont A, Bretagnol A, Benzekri-Lefevre D, Kamel T, Muller G, Bercault N, Barbier F, Runge I, Nay MA, Skarzynski M, Mathonnet A, Boulain T. Effect of In-Bed Leg Cycling and Electrical Stimulation of the Quadriceps on Global Muscle Strength in Critically Ill Adults: A Randomized Clinical Trial. JAMA. 2018 Jul 24;320(4):368-378. doi: 10.1001/jama.2018.9592.

MeSH Terms

Conditions

Muscle WeaknessPolyneuropathies

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPeripheral Nervous System DiseasesNeuromuscular Diseases

Study Officials

  • Thierry Boulain, MD

    Centre Hospitalier Régional d'Orléans, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2014

First Posted

July 10, 2014

Study Start

July 15, 2014

Primary Completion

November 24, 2016

Study Completion

November 24, 2016

Last Updated

April 13, 2017

Record last verified: 2017-04

Locations